Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 41 out of 100. How common it is

Topic: Brain proteins, microglia and lab models

Plain-language summary

• This analysis consists of 567 participants revealed that vitamin B12 deficiency, not folate or vitamin B1 deficiency was associated with hippocampal atrophy detected by MRI-VSRAD analysis. • Vitamin B12 deficiency was associated with hyperhomocysteinemia. • Clear correlations were observed between hippocampal atrophy and vitamin B12 value. Vitamin deficiencies have been reported to cause brain atrophy. Hippocampal atrophy has been well reported in patients with dementia including Alzheimer’s disease. To investigate the association between hippocampal atrophy and vitamin deficiency Cross sectional study Three sites in one country Overall, 567 patients who visited an outpatient dementia clinic and underwent MRI-VSRAD (Voxel-Based Specific RegionalAnalysis System for Alzheimer's Disease) were included in this study. Patients with a hippocampal atrophy Z-score of < 2 were classified as normal ( n = 323), and those with a Z-score of ≥ 2 were diagnosed with hippocampal atrophy ( n = 244). Vitamin B 12 , folic acid, vitamin B 1 , homocysteine, HbA1c, and creatinine levels were measured and their association with hippocampal atrophy was assessed. Age, MMSE (Mini Mental State Examination), and hippocampal atrophy were also evaluated. In the hippocampal atrophy group, the frequency of vitamin B 12 deficiency was higher ( p < 0.022), MMSE score was lower ( p < 0.0001), and age was higher ( p < 0.0001) than that in the normal group (Mann-Whitney U test ). Patients with vitamin B 12 deficiency (odds ratio, 3.46) and low MMSE score (odds ratio, 2.24) had an increased risk of hippocampal atrophy. Vitamin B 12 deficiency was associated with hippocampal atrophy detected by VSRAD analysis. Therefore, early vitamin B 12 supplementation should be considered in patients with deficiencies to reduce dementia risk.

What this study adds

Evidence grade: Low

The record lists 323 participants. This cross-sectional study found that vitamin B12 deficiency, but not folate or vitamin B1 deficiency, was associated with hippocampal atrophy detected by MRI in a dementia cohort. It also observed clear correlations between hippocampal atrophy and vitamin B12 values, with vitamin B12 deficiency associated with hyperhomocysteinemia.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Ueno, A., Hamano, T., Nagata, M., Yamaguchi, T., Endo, Y., Enomoto, S., et al. (2025). Association of vitamin B12 deficiency in a dementia cohort with hippocampal atrophy on MRI. The Journal of Prevention of Alzheimer s Disease. https://doi.org/10.1016/j.tjpad.2025.100265

Vancouver

Ueno A, Hamano T, Nagata M, Yamaguchi T, Endo Y, Enomoto S, et al. Association of vitamin B12 deficiency in a dementia cohort with hippocampal atrophy on MRI. The Journal of Prevention of Alzheimer s Disease. 2025. doi:10.1016/j.tjpad.2025.100265. PMID: 40675920.

BibTeX

@article{ueno2025-40675920,
  author  = {Ueno, Asako and Hamano, Tadanori and Nagata, Miwako and Yamaguchi, Tomohisa and Endo, Yoshinori and Enomoto, Soichi and Kimura, Hirohiko and Ikawa, Masamichi and others},
  title   = {{Association of vitamin B12 deficiency in a dementia cohort with hippocampal atrophy on MRI}},
  journal = {The Journal of Prevention of Alzheimer s Disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100265},
  pmid    = {40675920},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100265}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

This cross-sectional study found that vitamin B12 deficiency, but not folate or vitamin B1 deficiency, was associated with hippocampal atrophy detected by MRI in a dementia cohort. It also observed clear correlations between hippocampal atrophy and vitamin B12 values, with vitamin B12 deficiency associated with hyperhomocysteinemia.

Study details

How this study scored 41/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 2 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 2 of 7; Citations per year 1 of 5; Impact for its field and year 3 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record left out, no data; Institution's track record 0 of 3; Multicenter collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. 39 of the 96 points it could be judged on, which is 41 of 100. Total 41 of 100.39 of the 96 points we could judge = 41 of 100

Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 39 of the 96 points we could judge it on, which is 41 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (The Journal of Prevention of Alzheimer s Disease)
Journal's citation record 0 / 4 The Journal of Prevention of Alzheimer s Disease: journal h-index 63 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 2 / 4 323 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 2 / 7 Cited 6 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 2.0 citations a year over 3 year(s) since 2025
Impact for its field and year 3 / 6 Cited 3.9× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 6 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record 0 / 3 University of Fukui: institution h-index 239 (OpenAlex)
Multicenter collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40675920)
Free to read 2 / 2 Free to read
Points 39 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 39 of the 96 points we could judge it on is 41 out of 100.
Total 41 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in How common it is from nearby years

Also tagged “biobank”

1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on How common it is

See all studies in How common it is →